BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25486429)

  • 1. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
    Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
    Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
    Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
    Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
    Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
    Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling.
    Matsumoto S; Fujii S; Kikuchi A
    J Biochem; 2017 Jan; 161(1):27-35. PubMed ID: 28053143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.
    Harada T; Matsumoto S; Hirota S; Kimura H; Fujii S; Kasahara Y; Gon H; Yoshida T; Itoh T; Haraguchi N; Mizushima T; Noda T; Eguchi H; Nojima S; Morii E; Fukumoto T; Obika S; Kikuchi A
    Mol Cancer Ther; 2019 Mar; 18(3):602-612. PubMed ID: 30647122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of Arl4c expression in colorectal cancer.
    Chen X; Su Z; Wang S; Xu H
    Cancer Biomark; 2016; 16(2):253-7. PubMed ID: 26756615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation.
    Fujii S; Ishibashi T; Kokura M; Fujimoto T; Matsumoto S; Shidara S; Kurppa KJ; Pape J; Caton J; Morgan PR; Heikinheimo K; Kikuchi A; Jimi E; Kiyoshima T
    J Pathol; 2022 Jan; 256(1):119-133. PubMed ID: 34622442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
    Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
    Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer.
    Kanai R; Uehara T; Yoshizawa T; Kamakura M; Nakajima T; Kinugawa Y; Iwaya M; Asaka S; Kitazawa M; Nagaya T; Ota H
    BMC Cancer; 2023 May; 23(1):478. PubMed ID: 37237373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures.
    Matsumoto S; Fujii S; Sato A; Ibuka S; Kagawa Y; Ishii M; Kikuchi A
    EMBO J; 2014 Apr; 33(7):702-18. PubMed ID: 24562386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.
    Xie N; Bai Y; Qiao L; Bai Y; Wu J; Li Y; Jiang M; Xu B; Ni Z; Yuan T; Shi Y; Wu K; Xu F; Wang J; Dong L; Liu N
    J Cell Mol Med; 2021 Apr; 25(8):4014-4027. PubMed ID: 33724652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
    Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
    Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion.
    Harada A; Matsumoto S; Yasumizu Y; Shojima K; Akama T; Eguchi H; Kikuchi A
    Elife; 2021 Sep; 10():. PubMed ID: 34590580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
    Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
    Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.